Teva Sub Says It Should Also Be Cut From FTC Androgel Suit
By Eric Kroh ( February 8, 2017, 4:50 PM EST) -- Teva subsidiary Actavis Holdco Inc. told a Georgia federal court Tuesday the government's dismissal of Par Pharmaceuticals Inc. supports its own bid to exit a lawsuit by the U.S. Federal Trade Commission alleging pharmaceutical companies illegally conspired to delay generic competition for AndroGel....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.